0001140361-12-040626.txt : 20120917 0001140361-12-040626.hdr.sgml : 20120917 20120917141118 ACCESSION NUMBER: 0001140361-12-040626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120913 FILED AS OF DATE: 20120917 DATE AS OF CHANGE: 20120917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYERS JONATHAN W CENTRAL INDEX KEY: 0001184149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 121094681 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2012-09-13 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184149 AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 Chairman, President & CEO Common Stock 2012-09-13 4 M 0 20000 17.135 A 366686 D Common Stock 2012-09-13 4 S 0 15000 99.2531 D 351686 D Non-Qualified Stock Options (right to buy) 17.135 2012-09-13 4 M 0 20000 0 D 2013-02-06 Common Stock 20000 84164 D The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 04/27/2012. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $98.64 to $99.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Grant of options to buy shares of common stock becomes exercisable as to 30,000 shares on 02/06/2004, 02/06/2005, 02/06/2006, 02/06/2007, and the remaining 24,164 shares on 02/06/2008. Jennifer L. Panciocco, Attorney-in-Fact for Jonanthan W. Ayers 2012-09-17